Connect with us
  • tg

Stock Markets

SoftBank trims stake in PB Fintech, sells shares to Goldman Sachs, Citigroup, and Saudi Central Bank

letizo News

Published

on

SoftBank trims stake in PB Fintech, sells shares to Goldman Sachs, Citigroup, and Saudi Central Bank
© Reuters

SoftBank (TYO:) has further reduced its stake in Indian technology company PB Fintech, the firm behind Policybazaar, by 2.5% on Friday. The shares were sold at Rs 760.8 each through a block deal involving buyers such as Goldman Sachs, Citigroup (NYSE:), and the Saudi Central Bank. The transaction, facilitated by Kotak Mahindra Capital, netted SoftBank Rs 869 crore.

This move is in line with SoftBank’s ongoing strategy of trimming its positions in Indian tech firms. It follows a previous divestment where SoftBank sold a 5.1% stake in PB Fintech for Rs 1,043 crore.

PB Fintech’s financial performance has remained strong throughout the year. The company has significantly reduced its consolidated net loss and reported a year-on-year revenue increase to Rs 666 crore. This robust financial performance has resulted in a considerable appreciation of PB Fintech’s stock price, which has risen by 71% in 2023. According to InvestingPro, PB Fintech’s net income is expected to grow this year, and it has been a prominent player in the Insurance industry, despite not being profitable over the last twelve months.

Technical analysts have pointed out an Inverse Head and Shoulders and Triangle Pattern in the company’s stock chart. They identify Rs 720 as the demand zone for any correction and Rs 820 as the immediate resistance level.

However, it’s worth noting that PB Fintech’s revenue growth has been slowing down recently, as per InvestingPro Tips. The company is also trading at a high Price / Book multiple, which means it could be overvalued. For more insights like these, you can visit InvestingPro. They offer a range of tips, with an additional 4 tips available for PB Fintech alone.

Despite the slowdown in revenue growth, PB Fintech’s stock price has seen a large uptick over the last six months. Moreover, analysts predict the company will be profitable this year, which might explain the high Price / Book multiple. It’s also worth noting that PB Fintech does not pay a dividend to shareholders, which is a factor potential investors may want to consider.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Stock Markets

Kuehn Law Encourages Investors of Riot Platforms, Inc. to Contact Law Firm

letizo News

Published

on

New York, New York–(Newsfile Corp. – December 28, 2024) – Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Riot Platforms, Inc. (NASDAQ: NASDAQ:) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.

If you are a long-term RIOT stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call (833) 672-0814. The consultation and case are free with no obligation to you. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.

For additional information, please visit Shareholder Derivative Litigation – Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235430

Continue Reading

Stock Markets

Kuehn Law Encourages Investors of Krystal Biotech, Inc. to Contact Law Firm

letizo News

Published

on

New York, New York–(Newsfile Corp. – December 28, 2024) – Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Krystal Biotech , Inc. (NASDAQ: NASDAQ:) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.

If you are a long-term KRYS stockholder please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law, or call (833) 672-0814. The consultation and case are free with no obligation to you. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.

For additional information, please visit Shareholder Derivative Litigation – Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/235429

Continue Reading

Stock Markets

ProShares Files for ‘Hedged’ Bitcoin ETF Products: Details

letizo News

Published

on

U.Today – American ETP issuer ProShares has made another decisive move to expand its ETF products suite. The asset manager has applied to list three new Bitcoin-linked ETF products, with stock market native products as reserves. These filings come amid growing consideration of more leniency in U.S. SEC approvals next year with a new Chairman set to take office.

ProShares Bitcoin ETF filings

Per an update from ETF Store President Nate Geraci, the three filings from ProShares include the S&P 500 Bitcoin ETF, the Nasdaq-100 Bitcoin ETF and the Gold Bitcoin ETF, respectively.

Nate Geraci states these products are long in the underlying stocks or gold. These would now feature a short USD and long Bitcoin position using offerings. The dual-faced model of these new ETFs made him call the prospective offerings “BTC hedged ETFs.”

Since spot Bitcoin and ETF products secured approval from the U.S. SEC, there has been no slowing down in the number of filings.

While the number of crypto ETFs like , Hedera, and ETF products has grown, asset managers are also intensifying how these offerings target traditional finance products more closely.

Geraci aptly observed that “Bitcoin is starting to eat tradfi.”

Year of crypto Wall Street takeover

The timing of the current filing has triggered commentary from market experts on how unrelenting ETF issuers are in driving more reach for the product. Beyond the $5,500 Ethereum price forecast from Galaxy Digital (TSX:), the firm also issued a major ETF adoption prediction.

As noted, at least one big asset manager will allocate 2% of its Assets Under Management (AuM) to Bitcoin, underscoring the potential for the asset to go mainstream on Wall Street.

Already, many traditional firms are buying Bitcoin through ETFs, complementing the unrelenting acquisitions from spot buyers like MicroStrategy.

This article was originally published on U.Today

Continue Reading

Trending

©2021-2024 Letizo All Rights Reserved